Charles River Laboratories Intl. Inc vs Impinj Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B), while Impinj Inc trades at $177.62 (market cap $5.32B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 2.5× Impinj Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Impinj Inc nearer its low. Which is the better fit depends on your goals.
| CRL | PI | |
|---|---|---|
Market Cap | $13.46B | $5.32B |
Sector | Health | Technology |
52-Week High | $282.00 | $241.91 |
52-Week Low | $145.57 | $91.34 |
Enterprise Value | $16.30B | $5.45B |
Trailing returns across standard periods
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →